Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,104

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

Open access
Chakaya, Jeremiah, Khan, Mishal, Ntoumi, Francine, Aklillu, Eleni, Fatima, Razia, Mwaba, Peter, Kapata, Nathan, Mfinanga, Sayoki, Hasnain, Seyed Ehtesham, Katoto, Patrick D.M.C., Bulabula, André N.H., Sam-Agudu, Nadia A., Nachega, Jean B., Tiberi, Simon, McHugh, Timothy D., Abubakar, Ibrahim, Zumla, Alimuddin·2021·International Journal of Infectious Diseases

Abstract

The October 2020 Global TB report reviews TB control strategies and United Nations (UN) targets set in the political declaration at the September 2018 UN General Assembly high-level meeting on TB held in New York. Progress in TB care and prevention has been very slow. In 2019, TB remained the most common cause of death from a single infectious pathogen. Globally, an estimated 10.0 million people developed TB disease in 2019, and there were an estimated 1.2 million TB deaths among HIV-negative people and an additional 208, 000 deaths among people living with HIV. Adults accounted for 88% and children for 12% of people with TB. The WHO regions of South-East Asia (44%), Africa (25%), and the Western Pacific (18%) had the most people with TB. Eight countries accounted for two thirds of the global total: India (26%), Indonesia (8.5%), China (8.4%), the Philippines (6.0%), Pakistan (5.7%), Nigeria (4.4%), Bangladesh (3.6%) and South Africa (3.6%). Only 30% of the 3.5 million five-year target for children treated for TB was met. Major advances have been development of new all oral regimens for MDRTB and new regimens for preventive therapy. In 2020, the COVID-19 pandemic dislodged TB from the top infectious disease cause of mortality globally. Notably, global TB control efforts were not on track even before the advent of the COVID-19 pandemic. Many challenges remain to improve sub-optimal TB treatment and prevention services. Tuberculosis screening and diagnostic test services need to be ramped up. The major drivers of TB remain undernutrition, poverty, diabetes, tobacco smoking, and household air pollution and these need be addressed to achieve the WHO 2035 TB care and prevention targets. National programs need to include interventions for post-tuberculosis holistic wellbeing. From first detection of COVID-19 global coordination and political will with huge financial investments have led to the development of effective vaccines against SARS-CoV2 infection. The world now needs to similarly focus on development of new vaccines for TB utilizing new technological methods.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijid.2021.02.107

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 5

  1. Cox, 2018, Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis, Int J Tuberc Lung Dis, 22, 407, 10.5588/ijtld.17.0706 · doi:10.5588/ijtld.17.0706
  2. Gler, 2012, Delamanid for multidrug-resistant pulmonary tuberculosis, N Engl J Med, 366, 2151, 10.1056/NEJMoa1112433 · doi:10.1056/nejmoa1112433
  3. Kaplan, 1972, Tuberculosis in Alaska, 1970. The continued decline of the tuberculosis epidemic, Am Rev Respir Dis, 105, 920
  4. Trébucq, 2016, Numbers of tuberculosis cases: Dreams and reality, Int J Tuberc Lung Dis, 20, 1288, 10.5588/ijtld.15.0873 · doi:10.5588/ijtld.15.0873
  5. Zumla, 2020, COVID-19 and tuberculosis-threats and opportunities, Int J Tuberc Lung Dis, 24, 757, 10.5588/ijtld.20.0387 · doi:10.5588/ijtld.20.0387

Cited by

See all 1,104

Metadata

Authors
Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., Kapata, N., Mfinanga, S., Hasnain, S. E., Katoto, P. D. M. C., Bulabula, A. N. H., Sam-Agudu, N. A., Nachega, J. B., Tiberi, S., McHugh, T. D., Abubakar, I., & Zumla, A.
Venue
International Journal of Infectious Diseases
Publisher
Elsevier BV
Published
2021-12
Volume
113
Pages
S7-S12
ISSN
1201-9712 (ISSN-L)
OpenAlex
W3135682442
Cited by
1,104
References
31
FWCI
61.82
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts. https://app.cochat.ai/papers/10.1016/j.ijid.2021.02.107
The paper
Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., Kapata, N., Mfinanga, S., Hasnain, S. E., Katoto, P. D. M. C., Bulabula, A. N. H., Sam-Agudu, N. A., Nachega, J. B., Tiberi, S., McHugh, T. D., Abubakar, I., & Zumla, A. (2021). Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2021.02.107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.